BIWEEKLY CARBOPLATIN AND PACLITAXEL AS FIRST-LINE THERAPY FOR ELDERLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS (PHASE II STUDY)

被引：0
|
作者：
Kota, I. [1 ]
Soejima, K. [1 ]
Naoki, K. [1 ]
Yasuda, H. [1 ]
Terai, H. [1 ]
Daisuke, A. [1 ]
Ohgino, K. [1 ]
Yoda, S. [1 ]
Ikemura, S. [1 ]
Betsuyaku, T. [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：422 / 422
页数：1
相关论文
共 50 条
  • [1] Phase II study of biweekly carboplatin and paclitaxel as first-line treatment for elderly patients with advanced non-small cell lung cancer
    Terai, H.
    Soejima, K.
    Nakamura, M.
    Naoki, K.
    Yasuda, H.
    Satomi, R.
    Nakayama, S.
    Yoda, S.
    Ikemura, S.
    Sato, T.
    Asano, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Soejima, Kenzo
    Naoki, Katsuhiko
    Ishioka, Kota
    Nakamura, Morio
    Nakatani, Michie
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Yasuda, Hiroyuki
    Satomi, Ryosuke
    Nakayama, Sohei
    Yoda, Satoshi
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Ohgino, Keiko
    Arai, Daisuke
    Tani, Tetsuo
    Kuroda, Aoi
    Nishino, Makoto
    Betsuyaku, Tomoko
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 513 - 519
  • [3] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Kenzo Soejima
    Katsuhiko Naoki
    Kota Ishioka
    Morio Nakamura
    Michie Nakatani
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Hiroyuki Yasuda
    Ryosuke Satomi
    Sohei Nakayama
    Satoshi Yoda
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Keiko Ohgino
    Daisuke Arai
    Tetsuo Tani
    Aoi Kuroda
    Makoto Nishino
    Tomoko Betsuyaku
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 513 - 519
  • [4] BIWEEKLY AND CARBOPLATIN(CBDCA) AND PACLITAXEL(PTX) AS FIRST-LINE IS HOPEFUL THERAPY IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: PRELIMINARY RESULTS OF A PHASE II STUDY
    Terai, Hideki
    Soejima, Kenzo
    Nakamura, Morio
    Naoki, Katsuhiko
    Watanabe, Hideo
    Kawada, Ichiro
    Nakachi, Ichiro
    Yasuda, Hiroyuki
    Nakayama, Souhei
    Satomi, Ryousuke
    Yoda, Satoshi
    Ikemura, Shinnosuke
    Sato, Takashi
    Asano, Kouichirou
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1195 - S1196
  • [5] Biweekly docetaxel and carboplatin as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC). Finally results of a phase II study
    Firvida, J. L.
    Esquerdo, G.
    Amenedo, M.
    Salgado, M.
    LLorca, C.
    Perez, E.
    Cervera Grau, J.
    Ramos, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)
    Giorgio, CG
    Pappalardo, A
    Russo, A
    Giuffrida, D
    Santini, D
    Petralia, G
    Castorina, S
    Nunzio, R
    Failla, G
    Bordonaro, R
    [J]. LUNG CANCER, 2006, 51 (03) : 357 - 362
  • [7] Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancer
    Yanagitani, Noriko
    Tsuchiya, Satoshi
    Kaira, Kyoichi
    Sunaga, Noriaki
    Tsuchiya, Yukiko
    Sato, Koji
    Watanabe, Satoru
    Nomura, Shiro
    Sakai, Shuzo
    Saito, Ryusei
    Mori, Masatomo
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (05): : 487 - 491
  • [8] Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: A phase II study
    Jahanzeb, M
    Sarna, G
    Hirsch, R
    Radice, P
    Koletsky, A
    Martinez, M
    Kruglyak, E
    Wolin, E
    Camacho, E
    Kronish, L
    Motl, S
    [J]. ANTICANCER RESEARCH, 2004, 24 (2C) : 1239 - 1242
  • [9] A Phase Ii Study Of Carboplatin And Weekly Paclitaxel Combined With Bevacizumab For The First-Line Treatment Of Advanced Non-Small Cell Lung Cancer
    Kubota, T.
    Okano, Y.
    Sakai, M.
    Takaoka, M.
    Tsukuda, T.
    Anabuki, K.
    Kawase, S.
    Miyamoto, S.
    Ohnishi, H.
    Urata, T.
    Takeuchi, E.
    Ogushi, F.
    Yokoyama, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [10] A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer
    Yusuke Okuma
    Yukio Hosomi
    Satoshi Takahashi
    Yoshiro Nakahara
    Kageaki Watanabe
    Makoto Nagamata
    Yusuke Takagi
    Shinichiro Mikura
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 78 : 383 - 388
12345